Moderna Stock Plunge: Cancer Vaccine Selloff Triggers 25% Drop
A sudden Moderna stock plunge, a cancer vaccine selloff, gripped Wall Street on Thursday as shares crashed up to 25% after an unexpected, premature data leak overshadowed positive clinical trial results. Equity traders scrambled to process leaked partial trial metrics for the company’s personalized oncology candidate, intismeran autogene, sending the stock tumbling to an afternoon … Read more